NeuroOne Medical Technologies Corporation (NMTC) Gross margin 2021–2025
NeuroOne Medical Technologies Corporation (NMTC) gross margin by fiscal year — reported gross profit divided by reported revenue.
56.5%FY2025 · since FY2021: -54.9% → 56.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 56.5% | +25.2 pp |
| FY2024 | 31.3% | +7.9 pp |
| FY2023 | 23.4% | +64.7 pp |
| FY2022 | -41.4% | +13.5 pp |
| FY2021 | -54.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross profitNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →